Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Operating Income (2016 - 2025)

Nu-Med Plus' Operating Income history spans 10 years, with the latest figure at -$112341.0 for Q4 2021.

  • On a quarterly basis, Operating Income rose 77.78% to -$112341.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$839445.0, a 58.3% increase, with the full-year FY2025 number at -$48955.0, up 22.7% from a year prior.
  • Operating Income hit -$112341.0 in Q4 2021 for Nu-Med Plus, up from -$118366.0 in the prior quarter.
  • Over the last five years, Operating Income for NUMD hit a ceiling of $3.9 million in Q4 2017 and a floor of -$908467.0 in Q2 2020.
  • Historically, Operating Income has averaged -$74182.0 across 5 years, with a median of -$187208.5 in 2018.
  • Biggest five-year swings in Operating Income: soared 314.69% in 2017 and later tumbled 279.0% in 2018.
  • Tracing NUMD's Operating Income over 5 years: stood at $3.9 million in 2017, then tumbled by 109.12% to -$355401.0 in 2018, then skyrocketed by 42.12% to -$205704.0 in 2019, then tumbled by 145.73% to -$505482.0 in 2020, then surged by 77.78% to -$112341.0 in 2021.
  • Business Quant data shows Operating Income for NUMD at -$112341.0 in Q4 2021, -$118366.0 in Q3 2021, and -$251990.0 in Q2 2021.